Acute T cell lymphoblastic leukemia in the recipient of a renal transplant from a donor with malignant lymphoma.
Department of Hematooncology and Bone Marrow Transplantationt, Medical University of Lublin, Lublin, Poland.
Malgorzata
M
Kowal
Marek
M
Hus
Anna
A
Dmoszynska
Janusz
J
Kocki
Norbert
N
Grzasko
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002999:Clone Cells / Q000473:pathology / Q000637:transplantation; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D007165:Immunosuppression Therapy / Q000009:adverse effects; D017404:In Situ Hybridization, Fluorescence; D007676:Kidney Failure, Chronic / Q000150:complications / Q000601:surgery*; D016030:Kidney Transplantation / Q000009:adverse effects*; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D016399:Lymphoma, T-Cell / Q000175:diagnosis / Q000473:pathology*; D008297:Male; D008479:Mediastinal Neoplasms / Q000175:diagnosis / Q000473:pathology; D008875:Middle Aged; D009382:Neoplasms, Unknown Primary / Q000175:diagnosis / Q000473:pathology; D014411:Neoplastic Stem Cells / Q000473:pathology / Q000637:transplantation; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D013953:Thymus Neoplasms / Q000175:diagnosis / Q000473:pathology; D014019:Tissue Donors; D014184:Transplantation, Homologous / Q000009:adverse effects*